Historial de carrera de Richard Schoenfeld
Antiguos cargos conocidos de Richard Schoenfeld.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
PharmAthene, Inc. /Old/
 PharmAthene, Inc. /Old/ BiotechnologyHealth Technology PharmAthene, Inc. develops biotherapeutics to address biological pathogens and chemicals. It provides clinical and preclinical development for Bacillus anthracis a therapeutic anti-toxin for treatment of symptomatic patients infected with anthrax monoclonal. The company was founded in 2001 and is located in Annapolis, MD. | Director de Operaciones | 01/10/2005 | 09/08/2007 |
PharmAthene, Inc.
 PharmAthene, Inc. BiotechnologyHealth Technology PharmAthene, Inc. engages in the development and commercialization of medical countermeasures against biological and chemical threats. Its development portfolio includes a next generation anthrax vaccine that is intended to provide protection while having dosage and storage requirements. The company was founded in March 2001 and is headquartered in Annapolis, MD. | Corporate Officer/Principal | - | - |
Formación de Richard Schoenfeld.
| Northeastern University | Undergraduate Degree |
| St. Louis University | Masters Business Admin |
Estadísticas
Internacional
| Estados Unidos | 5 |
| España | 2 |
Operativa
| Chief Operating Officer | 1 |
| Doctorate Degree | 1 |
| Graduate Degree | 1 |
Sectorial
| Consumer Services | 4 |
| Health Technology | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 3 |
|---|---|
PharmAthene, Inc. /Old/
PharmAthene, Inc. /Old/ BiotechnologyHealth Technology PharmAthene, Inc. develops biotherapeutics to address biological pathogens and chemicals. It provides clinical and preclinical development for Bacillus anthracis a therapeutic anti-toxin for treatment of symptomatic patients infected with anthrax monoclonal. The company was founded in 2001 and is located in Annapolis, MD. | Health Technology |
| Polytechnic University | Consumer Services |
PharmAthene, Inc.
PharmAthene, Inc. BiotechnologyHealth Technology PharmAthene, Inc. engages in the development and commercialization of medical countermeasures against biological and chemical threats. Its development portfolio includes a next generation anthrax vaccine that is intended to provide protection while having dosage and storage requirements. The company was founded in March 2001 and is headquartered in Annapolis, MD. | Health Technology |
- Bolsa de valores
- Insiders
- Richard Schoenfeld
- Experiencia
